Sunday, 14 June 2020
fhrtuADAE wew
About the seminar: The role of market access is pivotal to ensure rapid and maintained access to medicines, devices and diagnostics to all appropriate patients who would benefit from treatment at the right price. Approval trends have shown to be greatly influenced by the introduction of Patient Access Schemes (PAS) and Managed Access Arrangements (MAA).
Changes to the regulatory landscape has allowed bodies such as NICE to issue guidance on technologies with an evidence base that is smaller or earlier in its evolution than has previously been the case. This has allowed patient access to certain interventions earlier, such as through the EMA ’s ‘Adaptive Pathways’ scheme. However, these methods will often have greater uncertainly regarding the clinical and cost-effectiveness at the point of decision making.
PAS are agreements reached by life sciences companies, reducing cost to the NHS , enabling patients to access cost-effective and innovative interventions. MAAs are increasingly introduced when conclusions on reimbursement cannot be made due to uncertainties in the clinical evidence and/or financial impact of an intervention and are designed to reduce the cost, in particular with orphans, ultra-orphans and cancer drugs. The same principles are beginning to be used with devices and diagnostics.
Christian Hill: Christian is a seasoned Market Access professional with over 18 years of experience in the International Biotech and Pharmaceutical industry. He has been involved in over 50 HTAs across Europe and has built up a strong network of key influencers including EU and national agencies. Prior to co-founding MAP in 2012, he led market access teams and submissions at InterMune, Gilead, Pfizer and Genzyme on a very broad range of products and disease areas from chronic disease to ultra-orphan indications.
https://ilde.upf.edu/v/46r6
https://ilde.upf.edu/v/46ri
https://ilde.upf.edu/v/46rr
https://ilde.upf.edu/v/46rv
https://ilde.upf.edu/v/46s8
https://ilde.upf.edu/v/46se
https://ilde.upf.edu/v/46sl
https://ilde.upf.edu/v/46sq
https://ilde.upf.edu/v/46sv
https://ilde.upf.edu/v/46t1
https://ilde.upf.edu/v/46tb
https://ilde.upf.edu/v/46tg
https://ilde.upf.edu/v/46tk
https://ilde.upf.edu/v/46tp
https://ilde.upf.edu/v/46tt
https://ilde.upf.edu/v/46ty
https://ilde.upf.edu/v/46u2
https://ilde.upf.edu/v/46u6
https://ilde.upf.edu/v/46ua
https://ilde.upf.edu/v/46ue
https://ilde.upf.edu/v/46ui
https://ilde.upf.edu/v/46um
https://ilde.upf.edu/v/46ur
https://ilde.upf.edu/v/46uw
https://ilde.upf.edu/v/46v1
https://ilde.upf.edu/v/46v6
https://ilde.upf.edu/v/46vb
https://ilde.upf.edu/v/46vj
https://ilde.upf.edu/v/46vt
https://ilde.upf.edu/v/46vy
https://ilde.upf.edu/v/46w3
https://ilde.upf.edu/v/46w8
https://ilde.upf.edu/v/46wc
https://ilde.upf.edu/v/46wh
https://ilde.upf.edu/v/46ws
https://ilde.upf.edu/v/46wx
https://ilde.upf.edu/v/46x1
https://ilde.upf.edu/v/46x6
https://ilde.upf.edu/v/46xb
https://ilde.upf.edu/v/46xf
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment